Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 24, 2026
Sygnature Discovery, a drug discovery contract research organization (CRO), announced a strategic brand relaunch, including a new website.
read more
Tuesday, February 24, 2026
Akums Drugs & Pharmaceuticals Ltd. has received European Union Good Manufacturing Practice (EU GMP) certification for two of its production sites in India.
read more
Tuesday, February 24, 2026
The Flamma Group announced that its Flamma USA site, located in Malvern, PA, has successfully passed its first FDA inspection.
read more
Wednesday, February 25, 2026
SteinCares and Shilpa Biologicals announced a strategic licensing agreement to commercialize a biosimilar across Latin America.
read more
Wednesday, February 25, 2026
Cellipont Bioservices announced a strategic collaboration with Soter Bio which will support integrated manufacturing pathways for complex cell therapy programs requiring coordinated biomolecule and cellular processing.
read more
Wednesday, February 25, 2026
Clinilabs announced the expansion of its European operations, including the establishment of its European Union headquarters at Switzerland Innovation Park Basel Area, and the appointment of Dr. Anne-Marie Nagy as executive vice president and head of...
read more
Wednesday, February 25, 2026
NorthX Biologics and Demeetra announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, together with advanced cell line development technologies ...
read more
ESTEVE CDMO announced that it had commenced a $15.5-million investment to enhance production capabilities and associated space at its newly acquired North American facility in Morton Grove, Illinois.
read more
BioDuro announced it has established a joint venture with Cenra API Solutions to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.
read more
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
read more
FUJIFILM Biotechnologies has launched ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics
read more
CellCarta announced the appointment of Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, Dr. El-Gabry will provide medical and scientific leadership across CellCarta's biomarker programs and lead the ...
read more
REPROCELL announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs).
read more
Symbiosis Pharmaceutical Services has appointed Joanne Anderson as chief commercial officer, strengthening the leadership team at the Stirling, UK–based contract development and manufacturing organization (CDMO).
read more
Wednesday, March 04, 2026
Codis announced a major expansion of its UK manufacturing capabilities with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. Codis will become the only UK CDMO offering this capacity. The addition will take place at its 400,...
read more